Literature DB >> 6309673

Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection.

M Palla, R Rizzi, M Toti, P Almi, M Rizzetto, F Bonino, R Purcell.   

Abstract

Hepatitis B surface antigen (HBsAg) bound to immunoglobulin M (IgM) was detected in sera of HBsAg carriers by a radioimmunoassay based on selective absorption of the immunoglobulin on a solid phase coated with antiserum to human IgM. Isopycnic banding and rate-zonal sedimentation have shown that the reaction is related to particulate forms of the HBsAg complexed with IgM. The binding of IgM possibly occurred because of a selective affinity of these molecules to the surface of HBsAg particles. HBsAg/IgM was found transiently in 24 of 25 (96%) patients with acute self-limited hepatitis B and persistently in 6 of 25 patients whose acute hepatitis B progressed to chronicity. It was also found in 20 of 39 (51%) chronic HBsAg carriers with inactive and asymptomatic infection. The HBsAg/IgM phenomenon is not dependent on replication of hepatitis B virions; its persistence in patients with acute hepatitis B may provide complementary evidence of transition of the infection to chronicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309673      PMCID: PMC264593          DOI: 10.1128/iai.41.3.950-958.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

2.  Antigenic sites related to human serum proteins in HBsAg: isolation from normal human serum of a high-molecular-weight glycoprotein reacting with antialbumin.

Authors:  A R Neurath; N Strick; C Y Huang; A M Prince
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

3.  HBsAg immune complexes in the course of infection with hepatitis B virus.

Authors:  K Madaliński; I Bragiel
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay.

Authors:  B G Hansson; R H Purcell
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Australia antigen-antibody complexes.

Authors:  I Millman; W T London; A I Sutnick; B S Blumberg
Journal:  Nature       Date:  1970-04-04       Impact factor: 49.962

6.  Detection of circulating immune complexes in hepatitis by means of a new method employing 125i-antibody. circulating immune complexes in hepatitis.

Authors:  G F Fresco
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-06

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen.

Authors:  P Kryger; L R Mathiesen; A M Møller; J Aldershvile; B G Hansson; J O Nielsen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

9.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

10.  Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line.

Authors:  S N Thung; M A Gerber
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

View more
  4 in total

1.  Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.

Authors:  S P Sylvan; U B Hellström; P R Lundbergh
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

2.  Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.

Authors:  K Madalinski; B Burczynska; K H Heermann; A Uy; W H Gerlich
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

3.  Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis.

Authors:  R Lahesmaa-Rantala; K Granfors; R Kekomäki; A Toivanen
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

4.  Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection.

Authors:  M Q Klinkert; L Theilmann; E Pfaff; H Schaller
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.